交易 DiaMedica Therapeutics Inc. - DMAC CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.0238 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 2.7431 | 0.0200 | 0.73% | 2.7231 | 2.7831 | 2.6431 |
Mar 27, 2024 | 2.6431 | -0.0800 | -2.94% | 2.7231 | 2.7231 | 2.6431 |
Mar 26, 2024 | 2.6531 | 0.0000 | 0.00% | 2.6531 | 2.7431 | 2.6431 |
Mar 25, 2024 | 2.6731 | -0.0700 | -2.55% | 2.7431 | 2.8931 | 2.6231 |
Mar 22, 2024 | 2.7231 | 0.1100 | 4.21% | 2.6131 | 3.2231 | 2.3931 |
Mar 21, 2024 | 2.6731 | -0.1000 | -3.61% | 2.7731 | 2.7831 | 2.6431 |
Mar 20, 2024 | 2.7631 | 0.0200 | 0.73% | 2.7431 | 2.7931 | 2.6131 |
Mar 19, 2024 | 2.8131 | 0.0600 | 2.18% | 2.7531 | 2.8431 | 2.7431 |
Mar 18, 2024 | 2.8431 | 0.0200 | 0.71% | 2.8231 | 2.9531 | 2.8231 |
Mar 15, 2024 | 3.0031 | 0.1800 | 6.38% | 2.8231 | 3.0031 | 2.8231 |
Mar 14, 2024 | 2.8431 | 0.0000 | 0.00% | 2.8431 | 2.8731 | 2.8431 |
Mar 13, 2024 | 2.8931 | 0.0900 | 3.21% | 2.8031 | 2.9331 | 2.7931 |
Mar 12, 2024 | 2.8731 | 0.0700 | 2.50% | 2.8031 | 2.9131 | 2.7831 |
Mar 11, 2024 | 2.8931 | -0.1000 | -3.34% | 2.9931 | 3.0531 | 2.8431 |
Mar 8, 2024 | 3.0431 | 0.1000 | 3.40% | 2.9431 | 3.1131 | 2.9431 |
Mar 7, 2024 | 3.0431 | 0.0300 | 1.00% | 3.0131 | 3.0631 | 2.9331 |
Mar 6, 2024 | 3.0131 | 0.0100 | 0.33% | 3.0031 | 3.0931 | 2.9731 |
Mar 5, 2024 | 3.0631 | 0.0600 | 2.00% | 3.0031 | 3.2131 | 3.0031 |
Mar 4, 2024 | 3.2050 | 0.2050 | 6.83% | 3.0000 | 3.2700 | 2.9900 |
Mar 1, 2024 | 3.0700 | 0.0502 | 1.66% | 3.0198 | 3.1490 | 2.9500 |
DiaMedica Therapeutics Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 13, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 DiaMedica Therapeutics Inc Earnings Release Q1 2024 DiaMedica Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Thursday, May 16, 2024 | ||
時間 (UTC) 18:00 | 國家 US
| 事件 DiaMedica Therapeutics Inc Annual Shareholders Meeting DiaMedica Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0.5 |
總營業費用 | 14.001 | 13.646 | 12.699 | 11.593 | 7.261 |
銷售/一般/行政費用,總計 | 6.162 | 4.881 | 4.389 | 3.693 | 2.739 |
研究與開發 | 7.839 | 8.765 | 8.31 | 7.9 | 4.522 |
Depreciation / Amortization | |||||
營業收入 | -14.001 | -13.646 | -12.699 | -11.593 | -6.761 |
利息收入(費用),非經營淨值 | 0 | -0.039 | |||
其他,淨值 | 0.353 | 0.082 | 0.434 | 0.975 | 1.146 |
稅前淨收入 | -13.648 | -13.564 | -12.265 | -10.618 | -5.654 |
稅後淨收入 | -13.676 | -13.592 | -12.292 | -10.649 | -5.734 |
未計算非常項目前的淨收益 | -13.676 | -13.592 | -12.292 | -10.649 | -5.734 |
淨收入 | -13.676 | -13.592 | -12.292 | -10.649 | -5.734 |
普通股股東可獲收益 (不含非經常性項目) | -13.676 | -13.592 | -12.292 | -10.649 | -5.734 |
普通股股東可獲收益 (含非經常性項目) | -13.676 | -13.592 | -12.292 | -10.649 | -5.734 |
攤薄淨收入 | -13.676 | -13.592 | -12.292 | -10.649 | -5.734 |
攤薄後加權平均股 | 26.4431 | 20.7734 | 15.6803 | 11.9877 | 7.74352 |
扣除特別項目的每股攤薄盈利 | -0.51719 | -0.6543 | -0.78391 | -0.88833 | -0.74049 |
每股正常攤薄盈利 | -0.51719 | -0.6543 | -0.78391 | -0.88833 | -0.74049 |
收入 | 0 | 0.5 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 4.741 | 5.521 | 3.973 | 3.128 | 3.364 |
銷售/一般/行政費用,總計 | 2.198 | 1.903 | 1.703 | 1.488 | 1.409 |
研究與開發 | 2.543 | 3.618 | 2.27 | 1.64 | 1.955 |
營業收入 | -4.741 | -5.521 | -3.973 | -3.128 | -3.364 |
其他,淨值 | 0.271 | 0.256 | 0.229 | 0.076 | 0.013 |
稅前淨收入 | -4.47 | -5.265 | -3.744 | -3.052 | -3.351 |
稅後淨收入 | -4.477 | -5.272 | -3.751 | -3.059 | -3.358 |
未計算非常項目前的淨收益 | -4.477 | -5.272 | -3.751 | -3.059 | -3.358 |
淨收入 | -4.477 | -5.272 | -3.751 | -3.059 | -3.358 |
普通股股東可獲收益 (不含非經常性項目) | -4.477 | -5.272 | -3.751 | -3.059 | -3.358 |
普通股股東可獲收益 (含非經常性項目) | -4.477 | -5.272 | -3.751 | -3.059 | -3.358 |
攤薄淨收入 | -4.477 | -5.272 | -3.751 | -3.059 | -3.358 |
攤薄後加權平均股 | 27.312 | 26.4489 | 26.4431 | 26.4431 | 26.4431 |
扣除特別項目的每股攤薄盈利 | -0.16392 | -0.19933 | -0.14185 | -0.11568 | -0.12699 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.16392 | -0.19933 | -0.14185 | -0.11568 | -0.12699 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 33.835 | 45.439 | 27.921 | 8.836 | 17.972 |
現金和短期投資 | 33.502 | 45.112 | 27.507 | 7.878 | 16.823 |
現金 | 4.728 | 4.707 | 7.409 | 3.883 | 16.823 |
應收賬款總額,淨額 | 0.082 | 0.13 | 0.34 | 0.823 | 0.78 |
預付的費用 | 0.209 | 0.084 | 0.064 | 0.047 | 0.369 |
總資産 | 34.395 | 45.551 | 28.095 | 9.053 | 18.339 |
物業/廠房/設備,總計 - 淨額 | 0.56 | 0.112 | 0.174 | 0.217 | 0.096 |
物業/廠房/設備,總計 - 總額 | 0.64 | 0.179 | 0.231 | 0.26 | |
累計折舊,總計 | -0.08 | -0.067 | -0.057 | -0.043 | |
流動負債總額 | 2.168 | 1.524 | 2.028 | 1.318 | 1.296 |
應付賬款 | 0.734 | 0.509 | 1.099 | 0.182 | |
預提費用 | 1.428 | 1.011 | 0.923 | 1.13 | |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0 | ||||
負債總額 | 2.568 | 1.527 | 2.081 | 1.436 | 1.314 |
長期債務總額 | 0.004 | 0.003 | 0.007 | 0.013 | 0.018 |
其他負債,總計 | 0.396 | 0 | 0.046 | 0.105 | |
股權 | 31.827 | 44.024 | 26.014 | 7.617 | 17.025 |
普通股 | 0 | 0 | 0 | 0 | 0 |
額外實收資本 | 128.078 | 126.576 | 94.925 | 64.232 | 62.993 |
留存收益(累計赤字) | -96.177 | -82.501 | -68.909 | -56.617 | -45.968 |
其他權益,總計 | -0.074 | -0.051 | -0.002 | 0.002 | |
總負債和股東權益 | 34.395 | 45.551 | 28.095 | 9.053 | 18.339 |
已發行普通股總數 | 26.4431 | 26.4431 | 18.7462 | 12.0069 | 11.9569 |
應收賬款 - 貿易,淨額 | 0.08 | 0.13 | 0.78 | ||
其他長期資産,總計 | 0 | 0.271 | |||
Payable/Accrued | 1.291 | ||||
長期債務的當前部分/資本租賃 | 0.006 | 0.004 | 0.006 | 0.006 | 0.005 |
資本租賃義務 | 0.004 | 0.003 | 0.007 | 0.013 | 0.018 |
短期投資 | 28.774 | 40.405 | 20.098 | 3.995 | |
其他流動資産,總計 | 0.042 | 0.113 | 0.01 | 0.088 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 47.886 | 41.231 | 29.674 | 33.835 | 36.49 |
現金和短期投資 | 46.465 | 40.368 | 28.655 | 33.502 | 36.084 |
現金 | 2.147 | 4.728 | 2.771 | ||
短期投資 | 44.233 | 34.529 | 26.508 | 28.774 | 33.313 |
應收賬款總額,淨額 | 0.31 | 0.188 | 0.057 | 0.082 | 0.075 |
預付的費用 | 0.396 | 0.616 | 0.87 | 0.209 | 0.322 |
總資産 | 58.139 | 62.05 | 30.217 | 34.395 | 37.041 |
物業/廠房/設備,總計 - 淨額 | 0.507 | 0.523 | 0.543 | 0.56 | 0.551 |
物業/廠房/設備,總計 - 總額 | 0.604 | 0.612 | 0.626 | 0.64 | 0.624 |
累計折舊,總計 | -0.097 | -0.089 | -0.083 | -0.08 | -0.073 |
流動負債總額 | 2.17 | 1.946 | 2.814 | 2.168 | 1.542 |
應付賬款 | 0.863 | 0.856 | 1.78 | 0.734 | 0.864 |
預提費用 | 1.305 | 1.087 | 1.029 | 1.428 | 0.671 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.002 | 0.003 | 0.005 | 0.006 | 0.007 |
負債總額 | 2.51 | 2.307 | 3.195 | 2.568 | 1.962 |
長期債務總額 | 0.003 | 0.004 | 0.004 | 0.004 | 0.005 |
資本租賃義務 | 0.003 | 0.004 | 0.004 | 0.004 | 0.005 |
其他負債,總計 | 0.337 | 0.357 | 0.377 | 0.396 | 0.415 |
股權 | 55.629 | 59.743 | 27.022 | 31.827 | 35.079 |
普通股 | 0 | 0 | 0 | 0 | 0 |
額外實收資本 | 166.153 | 165.732 | 128.5 | 128.078 | 127.667 |
留存收益(累計赤字) | -110.397 | -105.926 | -101.449 | -96.177 | -92.426 |
其他權益,總計 | -0.127 | -0.063 | -0.029 | -0.074 | -0.162 |
總負債和股東權益 | 58.139 | 62.05 | 30.217 | 34.395 | 37.041 |
已發行普通股總數 | 37.9537 | 37.9494 | 26.465 | 26.4431 | 26.4431 |
應收賬款 - 貿易,淨額 | 0.31 | 0.188 | 0.055 | 0.08 | 0.075 |
其他流動資産,總計 | 0.715 | 0.059 | 0.092 | 0.042 | 0.009 |
現金等價物 | 2.232 | 5.839 | |||
長期投資 | 9.746 | 20.296 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -13.676 | -13.592 | -12.292 | -10.649 | -5.734 |
經營活動産生的現金 | -11.511 | -12.252 | -9.185 | -9.102 | -5.696 |
經營活動産生的現金 | 0.025 | 0.024 | 0.021 | 0.021 | 0.015 |
非現金物品 | 1.555 | 1.777 | 1.891 | 1.139 | 0.659 |
已付現金利息 | 0.002 | 0.002 | |||
營運資金的變化 | 0.585 | -0.461 | 1.195 | 0.387 | -0.636 |
投資活動産生的現金 | 11.538 | -20.537 | -16.134 | -3.908 | -0.05 |
資本支出 | -0.081 | -0.022 | -0.047 | -0.002 | -0.05 |
融資活動産生的現金 | -0.006 | 30.087 | 28.845 | 0.07 | 21.216 |
股票的發行(報廢),淨額 | 0 | 30.093 | 28.85 | 0.075 | 21.216 |
外彙效應 | |||||
現金淨變化 | 0.021 | -2.702 | 3.526 | -12.94 | 15.47 |
Cash Taxes Paid | 0.027 | 0.028 | 0.036 | 0.026 | |
其他投資現金流量項目,總計 | 11.619 | -20.515 | -16.087 | -3.906 | |
債務的發行(退還),淨額 | -0.006 | -0.006 | -0.005 | -0.005 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -5.272 | -13.676 | -9.925 | -6.866 | -3.508 |
Cash From Operating Activities | -5.089 | -11.511 | -8.745 | -6.384 | -3.888 |
Cash From Operating Activities | 0.007 | 0.025 | 0.019 | 0.012 | 0.006 |
Non-Cash Items | 0.234 | 1.555 | 1.256 | 0.864 | 0.443 |
Changes in Working Capital | -0.058 | 0.585 | -0.095 | -0.394 | -0.829 |
Cash From Investing Activities | 2.509 | 11.538 | 6.814 | 4.742 | 2.214 |
Capital Expenditures | -0.007 | -0.081 | -0.049 | -0.006 | 0 |
Other Investing Cash Flow Items, Total | 2.516 | 11.619 | 6.863 | 4.748 | 2.214 |
Cash From Financing Activities | -0.001 | -0.006 | -0.005 | -0.003 | -0.001 |
Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Debt, Net | -0.001 | -0.006 | -0.005 | -0.003 | -0.001 |
Net Change in Cash | -2.581 | 0.021 | -1.936 | -1.645 | -1.675 |
Cash Taxes Paid | 0.014 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易